Stock INDP INDAPTUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Indaptus Therapeutics, Inc.

Equities

INDP

US45339J1051

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-29 pm EDT 		5-day change 1st Jan Change
2.122 USD +0.56% Intraday chart for Indaptus Therapeutics, Inc. -13.04% +20.56%
Mar. 14 Top Premarket Gainers MT
Mar. 13 Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Price Target on Indaptus Therapeutics to $12 From $15, Maintains Buy Rating
MT
HC Wainwright Reiterates Indaptus Therapeutics at Buy With $15 Price Target
MT
HC Wainwright Upgrades Indaptus Therapeutics to Buy From Neutral, Sets $15 Price Target
MT
INDAPTUS THERAPEUTICS : Maxim Group Upgrades Indaptus Therapeutics to Buy Rating From Hold, Sets $16 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INDP Stock
  4. News Indaptus Therapeutics, Inc.
  5. Analyst Reco.